Form:	P-MRI Transperineal Biopsy v6.0

CDE ID	CDE Description
* 421	EDRN Participant ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 422)
* 422	EDRN Site ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 2596)
* 2596	Date of biopsy (MM/DD/YYYY) (Go To: 2705)
* 2705	Indication for current prostate biopsy (Check all that apply.) (Go To: 844)
	Permissible Values (value): Rising PSA (1)
	Elevated PSA (2)
	Abnormal DRE (3)
	Atypical small acinar proliferation (ASAP) (6)
	Family history (7)
	High grade PIN (8)
	Elevated PSA velocity (>0.4 ng/ml/yr) (22)
	Abnormal laboratory tests (26)
	Other, specify: (97) (Go To: 1578)
* 1578	Indication for prostate biopsy, other specify: (Go To: 844)
* 844	Date pathology report completed (MM/DD/YYYY): (Go To: 839)
839	ID number of local pathology report: (Go To: 4781)
* 4781	Patholgy performed (Go To: 1595)
	Permissible Values (value): Locally (1)
	Centrally (2)
	Unknown (99)
* 1595	Inflammation present? (Go To: 1598)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 1598	Atrophy? (Go To: 2722)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 2722	Prostate volume (cc): (Go To: 1586)
* 1586	Presence of prostate adenocarcinoma: (Go To: 4541)
	Permissible Values (value): Malignancy absent (1)
	Malignancy present (2) (Go To: 975)
* 975	Prostate T-Stage, Clinical (Go To: 2179)
	Permissible Values (value): T1a (4)
	T1b (5)
	T1c (6)
	T2a (8)
	T2b (9)
	T2c (10)
	T3a (12)
	T3b (13)
	T4 (14)
	TX (15)
* 2179	Prostate N-Stage, Clinical: (Go To: 1694)
	Permissible Values (value): NX (1)
	N0 (2)
	N1 (5)
* 1694	Prostate M-Stage, Clinical : (Go To: 4541)
	Permissible Values (value): MX (1)
	M0 (2)
	M1 (3)
	M1a (4)
	M1b (5)
	M1c (6)
* 4541	Was a MRI/US Fusion Biopsy performed? (Go To: 4879)
	Permissible Values (value): No (0) (Go To: 980)
	Yes (1) (Go To: 4879)
	Unknown (99)
* 4879	Type of MRI fusion biopsy (Go To: 980)
	Permissible Values (value): Invivo UraNav (1)
	Artemis (2)
	Cognitive (3)
	In-gantry (4)
	Other, specify: (97) (Go To: 4880)
	Unknown (99)
* 4880	Type of MRI fusion biopsy, other, specify (Go To: 980)
* 980	Total number of cores taken: (Go To: 2872)
* 2872	Total number of cores with cancer: (Go To: 2158)
	Permissible Values (value): 0 (0)
	1 (1)
	2 (2)
	3 (3)
	4 (4)
	5 (5)
	6 (6)
	7 (7)
	8 (8)
	9 (9)
	10 (10)
	11 (11)
	12 (12)
	13 (13)
	14 (14)
	15 (15)
	16 (16)
	17 (17)
	18 (18)
	19 (19)
	20 (20)
* 2158	Number of specimens: (Go To: 2159)
* 2159	Specimen line number or identifier (system-generated): (Go To: 2709)
* 2709	Specimen identifier: (Go To: 4539)
* 4539	Type of tissue targeting (Go To: 2160)
	Permissible Values (value): None (0)
	MRI targeting (1)
* 2160	Tissue position (laterality): (Go To: 2213)
	Permissible Values (value): Right (1)
	Left (2)
	Unilateral, side not specified (3)
	Bilateral (5)
	Other (95)
	Unknown (99)
* 2213	Tissue position (regionality): (Go To: 2212)
	Permissible Values (value): Apex (A) (1)
	Middle (M) (2)
	Base (B) (3)
	Unknown (99)
* 2212	Tissue position (position within region): (Go To: 2211)
	Permissible Values (value): Paramedian Medial (closest to the urethra) (4)
	Paramedian Lateral (5)
	Lateral edge (6)
	Other, specify: (97) (Go To: 5949)
	Unknown (99)
* 5949	Tissue position (position within region): (Other, specify) (Go To: 2211)
* 2211	Tissue position (zone): (Go To: 2712)
	Permissible Values (value): Transition Zone (TZ) (1)
	Seminal vesicle (2)
	Peripheral zone (4)
	Unknown (99)
* 2712	Specimen status (normal or abnormal): (Go To: 3158)
	Permissible Values (value): Normal (1)
	Positive for malignancy (3) (Go To: 1589)
	Abnormal but negative for malignancy (4) (Go To: 984)
	Unknown (99)
* 1589	Primary Gleason grade: (Go To: 1590)
* 1590	Secondary Gleason grade: (Go To: 1696)
1696	Tertiary Gleason Pattern: (Go To: 1697)
* 1697	Overall Gleason Score: (Go To: 2737)
* 2737	Histological type (prostate): (Go To: 2713)
	Permissible Values (value): Adenocarcinoma (4) (Go To: 2738)
	Sarcoma cell carcinoma (5)
	Squamous cell carcinoma (6)
	Transitional cell carcinoma (7)
	Unknown (99)
* 2738	Histological subtype: (check all that apply) (Go To: 2713)
	Permissible Values (value): Ductal (4)
	Mucinous (13)
	Neuroendocrine (15)
	Small cell carcinoma (19)
	Unknown (99)
* 2713	Method used to record quantity of cancer in specimen: (Go To: 984)
	Permissible Values (value): Percent cancer (1) (Go To: 2210)
	Length of cancer & length of specimen (2) (Go To: 2208)
	Unknown (99)
* 2210	Percent of cancer in tissue: (Go To: 2838)
* 2838	Notation for percent cancer value: (Go To: 984)
	Permissible Values (value): < less than (1)
	No notation (10)
	Other, specify: (97) (Go To: 2839)
	Unknown (99)
* 2839	Notation for percent cancer value (Other specify): (Go To: 984)
* 2208	Length of cancer in tissue specimen (mm): (Go To: 2209)
* 2209	Length of tissue specimen (mm): (Go To: 984)
* 984	High grade prostatic intraepithelial neoplasia (PIN)? (Go To: 1596)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 1596	Atypical small acinar proliferation (ASAP)? (Go To: 1597)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 1597	Atypia/Suspicious? (Go To: 1591)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 1591	Perineural invasion: (Go To: 4048)
	Permissible Values (value): Present (1)
	Absent (2)
	Unknown (99)
* 4048	Associated with intraductal carcinoma (ICD-P)? (Go To: 4969)
	Permissible Values (value): No (0)
	Yes (1)
	Uncertain (borderline case) (3)
	Unknown (99)
* 4969	Presence of cribriform pattern? (Go To: 3158)
	Permissible Values (value): No (0)
	Yes (1)
	Uncertain (borderline case) (3)
	Unknown (99)
3158	Loop-specific comments: (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)